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Uremia and insulin resistance: N-carbamoyl-asparagine
decreases insulin-sensitive glucose uptake in rat adipocytes
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Division of Nephrology, Department of Medicine and Department of Molecular Sciences, University of Tennessee Health
Science Center, Memphis, Tennessee
Uremia and insulin resistance: N-carbamoyl-asparagine de-
creases insulin-sensitive glucose uptake in rat adipocytes.
Background. In uremia, urea-derived cyanate reacts with
amino groups irreversibly forming carbamoyl amino acids (C-
AA) and carbamoyl proteins. Carbamoylated molecules can af-
fect binding and trafficking and alter metabolic pathways. The
C-AA role in insulin-sensitive glucose transport has not been
explored and may contribute to insulin resistance in uremia.
Methods. Insulin-stimulated glucose uptake by cultured rat
adipocytes was measured using both 3-minute and 3-second as-
says. Adipocytes were incubated for 24 hours in medium con-
taining 0.5 lmol/mL of 15 different C-AA. 125I-insulin binding
studies were done. C-asparagine in plasma from 10 uremic pa-
tients on continuous ambulatory peritoneal dialysis (CAPD)
was measured using high-performance liquid chromatography
(HPLC).
Results. Insulin-sensitive glucose uptake was reduced 34%
by N-carbamoyl-L-asparagine, (N-C-Asn), in a dose-dependent
manner with a half-maximally effective concentration of
0.15 lmol/mL. Fourteen other N-carbamoyl-amino acids as
well as 0.5 lmol/mL of asparagine did not affect insulin sen-
sitive glucose uptake. N-C-Asn, L-asparagine, and the other N-
carbamoyl amino acids (0.5 lmol/mL) had no effect on basal
glucose uptake. These data suggest that that N-C-Asn affects the
insulin sensitive glucose transporter system. 125I-insulin binding
studies demonstrated that N-C-Asn did not alter insulin bind-
ing. Glucose uptake measured using a 3-second assay showed
that the glucose affinity of the transporter and glucose phos-
phorylation were not affected. In uremic patients managed by
CAPD, the mean free N-C-Asn plasma level was 1.33 lmol/mL.
Conclusion. These data suggest that N-C-Asn concentration
may contribute to the insulin resistance seen in uremia.
The alteration of metabolic pathways in subjects with
diabetes mellitus and uremia may occur through post-
translational modification of proteins or alteration of
other molecules that are involved in glucose transport
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and metabolism. In diabetics, formation of advanced gly-
cation end products (AGE) [1] and in renal failure, car-
bamoylation by urea-derived cyanate [2, 3], alter protein
activity by modifying structure and charge of proteins. In
uremia, in vivo carbamoylation by urea-derived cyanate
irreversibly carbamoylates the a-amino and e-amino
groups of proteins [4] and reduces the free amino acid
pool by forming carbamoyl amino acids (C-AA) [5, 6].
Insulin carbamoylated by reaction with cyanate in vitro
was reported to have one third the activity of insulin as
measured by immunoprecipitation and the binding of car-
bamoyl insulin to isolated rat hepatocytes was one fifth
that of insulin [7].
Since carbamoylated proteins, urea, or urea-derived
cyanate in uremia may affect insulin-sensitive glucose up-
take, the use of urea, urea-derived cyanate or carbamoyl
proteins was avoided in this study. Rather, alterations of
glucose uptake in cultured rat adipocytes were examined
in the presence of amino acids previously modified by
cyanate to form C-AA.
In the present study, both noninsulin-sensitive and
insulin-sensitive glucose uptake was measured in rat
adipocytes in the presence of 15 different C-AA. It was
found that only a-amino-carbamoyl-L-asparagine (N-C-
Asn), structure illustrated in Figure 1, affected the
insulin-sensitive glucose transporter system. The in vivo
plasma concentration of N-C-Asn is high in patients with
end-stage renal disease (ESRD) managed by continuous
ambulatory peritoneal dialysis (CAPD) when compared
to the in vitro N-C-Asn concentration in the studies
of insulin-sensitive glucose uptake in rat adipocytes.
Thus, N-C-Asn-mediated interference with the insulin-
sensitive glucose transport system may contribute to in-
sulin resistance in the uremic patient.
METHODS
Materials
C-AA and asparagine, HEPES, NaCl, sodium pyru-
vate, and insulin from bovine pancreas were obtained
from (Sigma Chemical Co., St. Louis, MO, USA) and
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Fig. 1. Carbamoylation of asparganine. Similarity between the structures of a-amino-carbamoyl-asparagine, the asparagine glycosylation site N57
in GLUT4 protein and glycosylated asparagines N57 in GLUT4.
others as follows: bovine serum albumin (BSA) (CRG-
7) (Armour Company, Kankakee, IL, USA); colla-
genase (Worthington Biochemicals, Freehhold, NJ);
Dulbecco’s modified Eagle’s medium (DMEM) (For-
mula #85-5053 w/D-glucose at 1.0 g/L, w/sodium pyru-
vate, w/L-glutamine, w/o L-leucine, w/o L-methionine, w/o
CaCl2, w/o NaHCO3, w/o calcium pantothenate, peni-
cillin, and streptomycin) (Gibco/Invitrogen, Carlsbad,
CA, USA), [125I](A14) human insulin (Amersham Bio-
science Corp., Piscataway, NJ, USA); [3H]-6-D-glucose
(New England Nuclear/ICN, Irvine, CA, USA).
Preparation of isolated adipocytes
Male Sprague-Dawley rats weighing 80 to 120 g were
killed by cervical dislocation, and the epididymal fat pads
were removed. Isolated adipocytes were obtained by col-
lagenase digestion of minced adipose tissue (1 to 2 g) af-
ter incubation at 37◦C for 50 minutes in 4 mL of DMEM
containing 25 mmol/L HEPES, collagenase (1.5 mg/mL),
and BSA (40 mg/mL) [8, 9]. The collagenase digest was
mixed with 20 mL of Hank’s-buffered balanced salt so-
lution (HBSS) containing 25 mmol/L Hepes (pH 7.4),
120 mmol/L NaCl, 2 mmol/L CaCl2, 2.5 mmol/L KCl, 1.2
mmol/L MgSO4, 1 mmol/L NaH2PO4, 1 mmol/L sodium
pyruvate, 5 mg/L phenol red, and 0.4% BSA (wt/vol) and
cells were filtered through nylon spectra/mesh screens of
decreasing size (1000 l, 500 l, and 250 l). The adipocytes
were centrifuged at 100 rpm for 20 seconds, washed three
times in sterile HBSS containing 40 mg/mL BSA (20 mL/
wash). After the last wash, cells were diluted to a final
volume equal to 12 mL of buffer/g of fat (final concen-
tration about ∼4.5 × 105 cells/mL) in DMEM containing
25 mmol/L HEPES (pH 7.4), 10 mg/mL BSA, 20 U/mL
penicillin, and 20 mg/mL streptomycin.
Adipocyte culture and washing procedure
Initially 15 different C-AA at 0, 25, 50, 100, or 200 lg/
mL were examined. Freshly prepared adipocytes were
added to DMEM (300 lL of cells/3 mL of DMEM, fi-
nal concentration ∼ 4.6 × 104 cell/mL) and were incu-
bated at 37◦C for 24 hours in the absence (control) or
presence of 0.5 lmol/mL of C-AA unless stated other-
wise. Control and treated cells were then washed three
times with warm (37◦C) HBSS containing 4 mg/mL BSA,
2 mL/wash, and infernate was removed. The cells were
concentrated to about 4.6×105 cells/mL by adding 200 lL
of HBSS/100 lL of cells to the culture medium and di-
vided into two groups to measure basal and maximally
insulin-stimulated rates of glucose uptake. These washing
procedures removed extracellular glucose and C-AA. All
cell groups were derived from a common pool of freshly
isolated cells, subjected to an equal number of washes,
and concentrated to the same final volume with HBSS
enabling direct comparisons among control and treated
cell groups.
Glucose transport assay
Basal and maximally insulin-stimulated rates of
glucose transport were determined by preincubating
adipocytes in the absence (basal) or presence of 20 ng/mL
of insulin for 30 minutes at 37◦C. One hundred eighty mi-
croliter aliquots containing ∼4.1 × 105 cells were placed
in 10 lL of HBSS or in 10 lL of 400 pg/lL insulin. Ini-
tial rates of glucose uptake were routinely measured by
adding 20 lL of HBSS containing 0.12 lCi of [3H]-6-
D-glucose and glucose (final substrate concentration of
50 lmol/L, final assay volume of 210 lL). After 3 min-
utes, the reaction was terminated by separating cells in
180 lL aliquots from buffer by centrifugation with 70 lL
Kraus et al: Carbamoyl-asparagine decreases insulin-sensitive glucose uptake 883
silicone oil [10]. To correct the glucose uptake values for
the uptake of hexose by simple diffusion and nonspecific
trapping of radioactivity in the cell pellet, glucose uptake
was assessed in the presence of 0.3 mmol/L phloretin [11].
In each experiment, glucose uptake was derived from the
mean of triplicate determinations.
Initial rates of [3H]-6-D-glucose were also measured
with a 3-second assay [11] to ensure the glucose trans-
port rates determined with the 3-minute assay accurately
reflected changes in transport rate and not hexokinase
activity. Cells (50 lL of 9.2 × 105 cells/mL, 1:6 dilu-
tion) were added to either 10 lL of HBSS or 10 lL of
400 pg/lL insulin and preincubated for 30 minutes at
37◦C. Glucose uptake rates were measured by adding
20 lL of HBSS containing 0.25 lCi of [3H]-6-D-glucose
(final concentration 86 nmol/L) and terminated after 10
seconds (basal) or 3 seconds (insulin) by adding 120 lL of
ice-cold 0.51 mmol/L phloretin solution and then placing
the tubes in an ice-bath until the other tubes were assayed
(less than 10 minutes). Cells in 180 lL aliquots were sep-
arated from buffer by centrifugation through silicone oil.
In each experiment, glucose uptake was derived from the
mean of six determinations for each cell group.
Measurement of cell surface insulin receptors
Specific [125I] insulin binding was measured after cells
were incubated in the absence (control) or presence of
0.5 lmol/mL N-C-Asn at 37◦C for 24 hours in DMEM.
Washed cells were then incubated with [125I]-insulin in
the absence of or presence of excess unlabeled insulin to
determine specific binding at 15◦C for 3 hours. Control
adipocytes or N-C-Asn, 0.5 lmol/mL, treated cells were
incubated for 24 hours at 37◦C in sterile culture (1 mL
of 7 × 105 cells/mL were added to a final volume of
10 mL DMEM, making a final cell concentration of 7 ×
104 cells/mL). Then cells were washed three times with
HBSS containing 4 mg/mL BSA. Cells were concentrated
to 7 × 105 cells/mL by adding 100 lL of DMEM per
100 lL of cells initially added to the culture medium.
Cells (100 lL of 7 × 105 cells/mL) were incubated in a
total volume of 200 lL of DMEM buffer (pH 7.8) with
0.2 ng/mL of [125I]-insulin (10 lL of 0.98 lCi/mL) in the
absence or presence of excess insulin (40 lg/mL, non-
specific binding tubes). Incubations were performed for
3 hours at 15◦C. Specific [125I]-insulin binding to intact
adipocytes was performed at 15◦C because insulin in-
ternalization is negligible at this low temperature; thus
cell-associated [125I]-insulin reflects binding to cell sur-
face receptors. The binding reaction was terminated, and
free [125I]-insulin was separated from cell-bound radioac-
tivity by removing 180 lL aliquots from the cell suspen-
sion and rapidly centrifuging the cells through silicone oil.
The cells were removed and the radioactivity determined.
Specific [125I]-insulin binding was measured in triplicate
from each incubation tube in five experiments.
Uremic patients
N-C-Asn was measured in plasma from patients with
ESRD that were managed by CAPD. Patients with dia-
betes were excluded from the study. All of the patients
were on a diet that provided 1.2 to 1.5 g protein per kilo-
gram of body weight per day, and changes were made for
caloric needs or sodium or potassium intake as required.
The peritoneal dialysis solution used for CAPD was stan-
dard Dianeal 1.5%, 2.5%, or 4.25% dextrose and was ob-
tained from Baxter Healthcare Corp. (McGaw Park, IL,
USA). Blood was collected at regular clinic visits. Patients
did not fast before coming to the clinic in order to main-
tain their daily routine. Postprandial venous blood sam-
ples were collected into ethylenediaminetetraacetic acid
(EDTA) and immediately refrigerated. Blood collection
was within a 4-hour period after the morning meal and
after the first dialysis exchange of the day. Cold samples
were centrifuged for 10 minutes at 1400g. Freshly pre-
pared plasma was stored at −80◦C until it was processed
for chromatography. Blood urea nitrogen was measured
with a CABAS Roche Biochemical instrument (Roche
Diagnostic Systems, Inc., Montclair, NJ, USA). The study
protocol was approved by the University of Tennessee
Health Science Center Institutional Review Board for
Protection of Human Subjects. Informed consent was ob-
tained from all patients.
Chromatographic analysis of N-C-Asn
Free N-C-Asn was separated and quantitated using
ion-pair-reverse-phase high performance liquid chro-
matography (HPLC) on a Sigma ODS-2, 5 mm (octade-
cylsilyl) column, 250 × 4.6 mm (serial number 93081259,
lot number 083H3535) (Sigma-Aldrich, Aldrich Chemi-
cal Co., Inc., Milwaukee, WI, USA). The ion-pair mobile
phase was 5 mmol/L tetrabutylammonium hydrogen sul-
fate (Supelco, Inc., Bellefonte, PA, USA) buffered with
50 mmol/L potassium phosphate to pH 4.75. An isocratic
system was used for the elution of N-C-Asn. A gradient
system with 80% methyl alcohol elutes other C-AA. Ab-
sorption was measured at 210 nm with an ISCO HPLC
system (ISCO, Inc., Lincoln, NE, USA) with ISCO Chem-
Research data management program on an IBM personal
computer (IBM Corp., Armonk, NY, USA). N-C-Asn
from patient samples was measured in protein-free ultra-
filtrate of plasma obtained with a Millipore Ultrafree-MC
10,000 NMWL Filter Unit for a 10,000 molecular weight
cut-off (Millipore Corporation, Bedford, MA, USA).
Statistical analysis
Analysis was preformed by analysis of variance
(ANOVA) and the Student t test.
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RESULTS
N-C-Asn did not affect insulin binding to adipocytes
Specific [125I]-insulin binding measured as the ratio
of bound divided by free multiplied by 100 was 1.58 ±
0.06 (mean ± SEM of five experiments) for the control
adipocytes and 1.56 ± 0.04 (mean ± SEM) for N-C-Asn–
treated cells, indicating that N-C-Asn induced decrease
in insulin sensitive uptake must occur at a post-binding
site.
Effect of C-AA on the rate of insulin-sensitive
and insulin-insensitive glucose uptake
Of 15 C-AA examined, only N-C-Asn modified the rate
of insulin-stimulated glucose uptake in freshly isolated rat
adipocytes (Fig. 2). N-C-Asn caused a decrease in insulin-
stimulated glucose uptake in the adipocytes (Fig. 2C).
Basal glucose uptake without insulin was not affected by
C-AA (Fig. 2B). Insulin-sensitive glucose uptake rate in
N-C-Asn–treated cells was reduced to 156 ± 10 pmol/
3 min (mean ± SEM) as compared to 243 ± 4.8 pmol/
3 min in untreated cells. These results indicate that the ef-
fect of N-C-Asn on glucose uptake by cultured adipocytes
was specific for the insulin-sensitive glucose transporter
system. GLUT4 is the protein glucose transporter of the
insulin-sensitive glucose transporter system [12–14] and
GLUT1 is the protein glucose transporter of the glucose-
insensitive (basal) glucose transported system [15].
Effect of N-C-Asn and L-asparagine on insulin-sensitive
glucose uptake
The N-C-Asn-induced decrease in the rate of insulin-
sensitive glucose uptake was compared to the effect of L-
asparagine to determine if L-asparagine had the same ef-
fect as N-C-Asn. The insulin sensitive glucose uptake rate
in cells treated with N-C-Asn was significantly decreased
(P < 0.001) when compared with either L-asparagine
(0.5 lmol/mL) or compared with untreated cells
(Fig. 3A). The rate of insulin-sensitive glucose uptake
decreased in a dose-dependent manner with a half-
maximally effective concentration of 0.15 lmol/mL of
N-C-Asn when adipocytes were incubated with various
concentrations of N-C-Asn (Fig. 3B). The percent in-
hibition caused by various concentrations of N-C-Asn
plateaued at 34% (Fig. 3C).
The effect of N-C-Asn is on glucose uptake, not on glu-
cose phosphorylation
The rate of glucose uptake in cells was measured using
a 3-second assay since the observed rate of glucose uptake
is essentially independent of glucose phosphorylation at
short time periods [11]. Thus, the 34% N-C-Asn induced
decrease in the rate of insulin-stimulated glucose uptake
at 3 seconds (Fig. 4) was due to an effect on transport,
and not due to glucose phosphorylation.
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Fig. 2. Effect of N-carbamoyl-L-amino acids on glucose uptake in iso-
lated rat adipocytes. Isolated rat adipocytes were incubated for 24 hours
in Dulbecco’s modified Eagle’s medium (DMEM) in the absence (con-
trol) or presence of 0.5 lmol/mL of N-carbamoyl amino acids. After
24 hours, the cells were washed and then preincubated for 40 minutes
in 37◦C in the presence (A) or absence (B) of insulin (50 ng/mL) af-
ter which the rate [3H]-6-D-glucose uptake was measured. The rate of
insulin-sensitive glucose uptake (C) was determined by subtracting the
rate of glucose uptake measured in the absence of insulin (B) from that
measured in the presence of insulin (A). Each bar represents the mean
± SEM of three experiments (A) or four experiments (B) measured
in triplicate. The rate of glucose uptake by adipocytes incubated in the
absence of N-carbamoyl amino acids was compared with the rate of
uptake in cells incubated in the presence of N-carbamoyl amino acids
using the Student t test. ∗∗P < 0.01.
Effect of N-C-Asn on the glucose affinity of basal- and
insulin-stimulated transporters
Since N-C-Asn appears to be acting at a post-binding
site within the glucose transporter system, we measured
the kinetics of glucose uptake in control and N-C-Asn–
treated adipocytes for both basal- and insulin-stimulated
glucose uptake. The glucose KM was measured as mmol/L
(mean ± SEM, N = 4 measured in triplicate). The KM for
glucose uptake without either insulin or N-C-Asn was
8.14 ± 1.57. The KM when N-C-Asn was present with-
out insulin, was 7.83 ± 0.83. Thus, N-C-Asn had little
effect on the basal rate of glucose uptake. The KM for
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Fig. 3. Effect of L-asparagine and various concentrations of N-
carbamoyl-L-asparagine on insulin-sensitive glucose uptake in isolated
rat adipocytes. (A) Freshly isolated rat adipocytes were incubated for
24 hours in the absence (None), or presence of 0.5 lmol/mL L-
asparagine or N-carbamoyl-L-asparagine at 37◦C, washed, and the
rate of insulin-sensitive glucose uptake was determined as described
in Figure 2. (B) The effect of various concentration of N-carbamoyl-
asparagine on the rate of insulin-sensitive glucose uptake (arrow indi-
cates the half maximally effective concentration of 0.15 lmol/mL) in
isolated adipocytes and is expressed as percent inhibition (C). Each bar
in (A) represents the mean ± SEM of four experiments measured in
triplicate. The rate of insulin-sensitive glucose uptake in adipocytes in-
cubated in the absence of N-carbamoyl amino acids was compared to
that obtained with cells incubated with asparagines with or without the
N-carbamoyl modification using the Student t test. ∗∗∗P < 0.001.
insulin-sensitive glucose uptake without N-C-Asn was
6.04 ± 0.72 and when N-C-Asn was present with insulin it
was 5.35 ± 0.15. Although N-C-Asn decreased the Km for
glucose uptake in insulin-stimulated adipocytes, the de-
crease was not statistically significant (P = 0.08). These
results suggested that N-C-Asn induced decrease in
insulin-sensitive glucose uptake did not result from de-
creased binding of glucose to GLUT4.
N-C-Asn in uremic patients with ESRD maintained
by CAPD
Clinical parameters from non-diabetic patients (N =
10) with ESRD treated by CAPD from an ongoing study
of carbamoylation are reported in Table 1. The mean
N-C-Asn, 1.33 ± 0.09 SEM lmol/mL, in vivo in pa-
tient plasma was greater than the half-maximally effec-
tive concentration of N-C-Asn, 0.15 lmol/mL, which de-
creased insulin-sensitive glucose uptake by isolated rat
adipocytes. Thus carbamoylation of asparagine in uremic
patients may be a contributing factor to insulin resistance
present in uremic patients.
DISCUSSION
The underlying causes of the insulin resistance seen
in chronic renal failure remain unclear. Only N-C-Asn
(Fig. 1) affected the insulin-sensitive glucose transporter
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Fig. 4. Effect of N-carbamoyl-L-aspargine (N-C-Asn) on the rate of
[3H]-6-D-glucose uptake measured with a 3-second assay. Freshly iso-
lated adipocytes were incubated at 37◦C for 24 hours in the absence
(None) or presence of 0.5 lmol/mL N-C-Asn. After 24 hours, the cells
were washed and the rate of insulin-sensitive glucose uptake was deter-
mined as described in Figure 1. Each bar represents the mean ± SEM
of six experiments measured in triplicate. The rate of insulin-sensitive
glucose uptake in cells incubated in the absence of N-C-Asn (None)
was compared to that in cells incubated in the presence of N-C-Asn
using the Student t test. ∗∗∗P < 0.001.
system. These results directed attention to GLUT4, the
insulin regulated glucose transporter found in adipose
tissue and in heart and skeletal muscle. Early studies re-
ported the translocation of GLUT4 from a large intracel-
lular reserve to the plasma membrane in the adipocyte
following insulin stimulation [15]. Since GLUT4 trans-
fection into other cell types did not result in insulin-
stimulated GLUT4 translocation, additional studies iden-
tified proteins that, when targeted, resulted in translo-
cation of GLUT4. Multiple signaling transduction path-
ways and the downstream targets of phosphoinositide-3
kinases and other mechanisms involved in regulation of
glucose transport have been reported [16–18]. The loca-
tion of GLUT4-containing vesicles in the plasma mem-
brane can increase 10- to 20-fold with insulin stimulation
due to the induction of specific signal transduction path-
ways. Several models for translocation of GLUT4, includ-
ing the possibility of specific sequences within GLUT4 or
its associated vesicles that may specifically target these
GLUT4 vesicles in their location and recycling, have been
described [19, 20]. Decreased renal function, causing the
increase of urea and urea-derived cyanate, may result in
the carbamoylation of proteins involved in signal trans-
duction and translocation of GLUT4 by modifying their
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Table 1. Patient parameters
Age CAPD N-C-Asn BUN Creatinine Glucose Albumin Globulin Hemoglobin
Patient Gender years months lmol/mL mg/dL mg/dL mg/dL g/dL g/dL g/dL Hematocrit %
1 F 62 30 1.79 59 15.4 95 3.3 3.2 10.3 31.3
2 F 62 56 1.11 53 12.9 96 3.8 3.3 8.0 22.1
3 F 72 63 1.55 50 11.7 108 3.6 2.9 7.0 20.3
4 M 47 72 1.07 67 16.5 151 4.2 3.6 12.8 37.9
5 M 41 114 1.08 57 19.3 98 4.8 3.6 11.2 33.4
6 M 51 86 1.65 71 16.8 88 4.2 3.8 11.7 34.5
7 F 53 61 1.42 82 14.9 128 3.2 3.4 6.2 19.4
8 F 61 26 0.96 61 11.1 120 2.2 3.0 6.5 19.6
9 F 48 30 1.58 82 15.4 101 3.5 3.4 6.3 19.4
10 M 47 66 1.12 45 11.2 99 2.6 3.5 8.7 27.3
Mean ± SEM 54 ± 3 60 ± 7 1.33 ± 0.0 63 ± 4 14.5 ± 0.9 108 ± 6.1 3.5 ± 0.2 3.4 ± 0.1 8.9 ± 0.8 26.5 ± 2.3
Abbreviations are: CAPD, continuous ambulatory peritoneal dialysis; N-C-Asn, a-amino-carbamoyl-asparagine; BUN, blood urea nitrogen.
structure and their function. This suggests the necessity
for further exploration of the decrease in the insulin-
sensitive glucose uptake in the presence of N-C-Asn cou-
pled with studies of urea-derived cyanate carbamoylation
of the proteins necessary for signal transduction and traf-
ficking of GLUT4 in the uremic diabetic patient.
The glucose transporter [12–14], insulin action on glu-
cose transport, and translocation of glucose transporter
activity in the uremic patient are subject to alterations by
carbamoylation. The glucose clamp technique [21] pro-
vided a method to quantify the beta cell sensitivity to
glucose (the hyperglycemic clamp) and the tissue sen-
sitivity to insulin (euglycemic insulin clamp). Using this
method, glucose intolerance in uremic patients was exam-
ined before and after 10 weeks of three times per week
hemodialysis [22]. These studies showed that peripheral
tissue insensitivity to the action of insulin was present in
the ten uremic patients. In some patients, there was an im-
paired beta cell response to glucose. The defect was not
in the binding of insulin to its receptor but in the glucose
transport system or intracellular metabolism of glucose
[22]. After treatment by hemodialysis, the changes due
to uremia were diminished but did not return to normal.
Insulin resistance in uremia, a post receptor defect, is well
established [23–28]. Decreased levels of branched chain
amino acids have been reported in uremic patients [29,
30] but were elevated in diabetics [31]. C-AA were not
measured in these studies. In rats with increased blood
urea nitrogen (BUN), there was a decrease in total glu-
cose transporter concentration in adipocytes that was re-
flected by reduced translocation of glucose transporters
[32]. These results might be attributed to carbamoylation
by urea-derived cyanate forming C-AA where a blocked
a-amino group interferes with protein synthesis [33].
The effect of C-AA upon insulin-sensitive glucose up-
take in adipocytes had not been previously reported. In
uremia, an irreversible reaction of an amino group with
urea-derived cyanate, in vivo, results in formation of a-
and e-amino-C-AA [3]. The blocked amino group resem-
bles the amino group in a peptide bond (Fig. 1). The
amino acid N57 is the potential N-glycosylation site in
GLUT4 involved in insulin-sensitive glucose uptake [34].
The COOH-terminal domain of 30 amino acids, uniquely
found in GLUT4, contains a double leucine (489, 490),
which acts as a signal for rapid endocytosis and reten-
tion in intracellular compartments when insulin is absent
[35, 36]. Also, targeting information for intracellu-
lar sequestration is found within amino acids 498–505
(TELEYLGP) [37].
Results reported here demonstrate that of 15 C-AA
examined, only N-C-Asn affected the glucose-sensitive
uptake rate of the insulin-sensitive glucose transporter
system, decreasing it 34%. Asparagine had no effect. C-
AA did not cause changes in noninsulin-sensitive glucose
uptake by GLUT1. N-C-Asn did not alter insulin binding,
and did not affect glucose affinity of the GLUT4 trans-
porter or affect glucose phosphorylation. The N-C-Asn-
induced decrease in glucose transporter activity could be
the result of several different mechanisms: (1) N-C-Asn
competing with the consensus glycosylation site GLUT4
N57 thus decreasing glycosylation of Glut4; (2) the do-
mains within the amino acid sequence of GLUT4 that reg-
ulate subcellular compartmentalization and translocation
of GLUT4 may have enhanced activity in the presence of
N-C-Asn resulting in the rapid endocytosis and retention
of the Glut4 transporter; (3) N-C-Asn in the presence of
insulin may have resulted in a restricted redistribution of
GLUT4 to the cell surface; and (4) N-C-Asn could effect
the signal transduction cascade initiated by insulin, thus
interfering with GLUT4 transporter activity.
In ESRD patients treated by CAPD, the plasma con-
centration of N-C-Asn, is higher than the concentration
of N-C-Asn, which, in a dose-dependent manner, de-
creases insulin-sensitive glucose uptake in rat adipocytes.
This study provides new information for the further un-
derstanding of insulin resistance found in uremia.
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